Cargando…

Metreleptin Treatment in Three Patients with Generalized Lipodystrophy

Generalized lipodystrophy (GL) is a rare inherited or acquired disease characterized by widespread loss of subcutaneous fat, leading to leptin deficiency, ectopic fat deposition, and severe metabolic abnormalities. Previous studies have shown the benefit of leptin replacement (metreleptin) in amelio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musso, Carla, Major, Maria Laura, Andres, Eugenia, Simha, Vinaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217977/ https://www.ncbi.nlm.nih.gov/pubmed/28096701 http://dx.doi.org/10.4137/CCRep.S40196

Ejemplares similares

New advances in the treatment of generalized lipodystrophy: role of metreleptin
por: Rodriguez, Alexander J, et al.
Publicado: (2015)

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin
por: Esfandiari, Nazanene H., et al.
Publicado: (2019)

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report
por: Takeyari, Shinji, et al.
Publicado: (2019)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy
por: Vieira, Diana Branco, et al.
Publicado: (2022)

SAT089 Natural History Of Generalized Lipodystrophy Following Early Vs. Late Metreleptin Treatment
por: Brush, Maiah, et al.
Publicado: (2023)

Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019)

Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
por: Schweisberger, Cintya, et al.
Publicado: (2021)

Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy
por: Saydam, O, et al.
Publicado: (2021)

Marked Hypoleptinemia Precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2023)

Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report
por: Pedicelli, Stefania, et al.
Publicado: (2020)

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020)

Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy
por: Schlögl, Haiko, et al.
Publicado: (2023)

Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program
por: Ajluni, Nevin, et al.
Publicado: (2016)

SAT676 Severe Recurrent Pancreatitis In A Familial Partial Lipodystrophy Patient On Metreleptin
por: Sargin, Pinar, et al.
Publicado: (2023)

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy
por: Akinci, Baris, et al.
Publicado: (2020)

FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding
por: Bukhari, Khulood M, et al.
Publicado: (2023)

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide
por: Akinci, Baris, et al.
Publicado: (2020)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
por: Nagayama, Ayako, et al.
Publicado: (2021)

SAT-081 Advanced Lipoprotein Analysis Demonstrates Atherogenic Lipid Profile in Patients with Lipodystrophy That Improves after Metreleptin Treatment
por: Kinzer, Alexandra, et al.
Publicado: (2019)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
por: Özalkak, Şervan, et al.
Publicado: (2023)

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022)

The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges
por: Haymond, Morey W, et al.
Publicado: (2023)

Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
por: Lambadiari, Vaia, et al.
Publicado: (2021)

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports
por: Shibata, Yusuke, et al.
Publicado: (2018)

First Account of Psychological Changes Perceived by a Female with Congenital Leptin Deficiency upon Treatment with Metreleptin
por: Hebebrand, Johannes, et al.
Publicado: (2022)

Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis
por: Sahinoz, Melis, et al.
Publicado: (2018)

Congenital Generalized Lipodystrophy Type 2 in a Patient From a High-Prevalence Area
por: Gonzalo, Miranda Manrique, et al.
Publicado: (2017)

A Visual Diagnosis: Lipodystrophy
por: Bhat, Salman Zahoor, et al.
Publicado: (2023)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

Acquired Generalized Lipodystrophy Associated with Autoimmune Hepatitis and Low Serum C4 Level
por: Eren, Erdal, et al.
Publicado: (2010)

Retinopathy and Uveitis in Congenital Generalized Lipodystrophy with Hypertriglyceridemia and Uncontrolled Diabetes (Berardinelli–Seip Syndrome)
por: Rubaie, Khaled A., et al.
Publicado: (2020)

Congenital generalized lipodystrophy in two siblings from Saudi Arabia: A case report
por: Hummadi, Abdulrrahman, et al.
Publicado: (2022)

Unusual magnetic resonance imaging findings of cystic bone lesions in congenital generalized lipodystrophy
por: de Oliveira, TFT, et al.
Publicado: (2022)

Aggressive papillary thyroid carcinoma in a child with type 2 congenital generalized lipodystrophy
por: Lima, Grayce Ellen da Cruz Paiva, et al.
Publicado: (2019)

Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy
por: Su, Xueying, et al.
Publicado: (2017)

Untangling the Heterogeneity of Acquired Generalized Lipodystrophy
por: Cavdar, Umit, et al.
Publicado: (2021)

Scleredema in a Patient with AIDS-Related Lipodystrophy Syndrome
por: Yachoui, Ralph, et al.
Publicado: (2013)

Acromegaly with congenital generalized lipodystrophy – two rare insulin resistance conditions in one patient: a case report
por: Guerreiro, Vanessa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ig5p3jsb41k2qcfiu2ua7hv6a0